Deep Vein Thrombosis

Clinical Trial Finder

Many patients with deep vein thrombosis are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

General Practitioner-performed Compression Ultrasound for Deep Vein Thrombosis

Condition:   Deep Vein Thrombosis
Intervention:   Other: compression ultrasonography
Sponsor:   Azienda Sanitaria Locale ASL 6, Livorno
Not yet recruiting - verified April 2014

Venous Thrombectomy/Thrombolysis Outcome Registry

Conditions:   Deep Venous Thrombosis;   Post Thrombotic Syndrome
Sponsor:   Heart and Vascular Outcomes Research Institute
Active, not recruiting - verified April 2014

Personalized Medicine Decision-Making in a Virtual Clinical Setting

Conditions:   Deep Vein Thrombosis;   Blood Clots
Sponsors:   National Institutes of Health Clinical Center (CC);   National Human Genome Research Institute (NHGRI)
Recruiting - verified February 2014

Correlation Between Reticulated Platelets and Major Adverse Cardiac and Cerebrovascular Events After Noncardiac Surgery

Conditions:   Cardiac Death;   Congestive Heart Failure;   Angina Pectoris;   Stroke;   Pulmonary Embolism;   Deep Vein Thrombosis
Sponsor:   Technische Universität München
Recruiting - verified April 2014

Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism)

Conditions:   Pulmonary Embolism;   Thromboembolism;   Thrombosis;   Venous Thrombosis;   Venous Thromboembolism
Interventions:   Drug: BAY 59-7939;   Drug: BAY 59-7939;   Drug: ASA
Sponsor:   Bayer
Recruiting - verified April 2014

The Comparative Safety and Effectiveness of Warfarin and Dabigatran Prescribed in the Non-valvular Atrial Fibrillation Population With Humana Healthcare Coverage

Condition:   Atrial Fibrillation
Sponsor:   Boehringer Ingelheim
Not yet recruiting - verified April 2014

The 36-month Extension to Follow up Sub Study

Conditions:   Postphlebitic Syndrome;   Post-Thrombotic Syndrome;   Deep Vein Thrombosis
Sponsors:   Sir Mortimer B. Davis - Jewish General Hospital;   Canadian Institutes of Health Research (CIHR);   Heart and Stroke Foundation of Canada;   Sigvaris Corporation
Active, not recruiting - verified April 2014

Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer

Condition:   Prostate Cancer
Interventions:   Drug: bicalutamide;   Drug: buserelin;   Drug: flutamide;   Drug: goserelin acetate;   Drug: leuprolide acetate;   Drug: orteronel;   Drug: triptorelin
Sponsors:   Radiation Therapy Oncology Group;   National Cancer Institute (NCI)
Recruiting - verified April 2014

The Side of Implantable Central Vascular Catheters and Complications

Condition:   Upper Extremity Deep Vein Thrombosis, Secondary
Sponsor:   National Taiwan University Hospital
Recruiting - verified April 2014

Dose Adjusting Enoxaparin Thromboprophylaxis Dosage According to Anti-factor Xa Plasma Levels Improve Pregnancy Outcome

Conditions:   Fetal Demise;   Fetal Growth Restriction;   Preeclampsia;   Abruptio Placentae;   Thromboembolism
Intervention:   Drug: enoxaparin
Sponsor:   HaEmek Medical Center, Israel
Recruiting - verified March 2013

Effectiveness of Bridging Anticoagulation for Surgery (The BRIDGE Study)

Conditions:   Arterial Thromboembolic Events;   Atrial Fibrillation
Interventions:   Drug: Placebo;   Drug: Dalteparin
Sponsors:   Duke University;   National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified April 2014

Tranexamic Acid in Urologic Surgery

Conditions:   Bleeding;   Prostatectomy
Interventions:   Drug: Tranexamic Acid;   Drug: Placebo
Sponsor:   Università Vita-Salute San Raffaele
Completed - verified July 2010

Microplasmin Administered Via the Trellis-8 Infusion System for Treatment of Acute Iliofemoral DVT

Condition:   Deep Vein Thrombosis
Intervention:   Drug: microplasmin
Sponsors:   ThromboGenics;   Bacchus Vascular
Terminated - verified April 2014

Deep Vein Thrombosis (DVT) Prevention in Total Hip Arthroplasty: Continuous Enhanced Circulation Therapy (CECT) Versus Low Molecular Weight Heparin (LMWH)

Conditions:   Deep Vein Thrombosis of Lower Limb;   Pulmonary Embolism (PE);   Bleeding
Interventions:   Device: ActiveCare CECT device;   Drug: Enoxaparin
Sponsor:   Medical Compression Systems
Completed - verified February 2010

Get CardioSmart

You're Invited